Title
Category
Credits
Event date
Cost
  • Participation
$0.00
Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy that affects approximately 20,000 patients each year in the United States. Management of AML has changed little over the last several decades and outcomes remain unsatisfactory. However, recent drug discoveries and approvals show tremendous promise. This presentation will review the current treatment armamentarium of AML highlighting novel concepts and investigational agents in development.
  • Participation
$0.00
The Genitourinary Cancers Symposium co-sponsored by the American Society of Clinical Oncology (ASCO), American Society for Radiation Oncology (ASTRO), and Society of Urologic Oncology (SUO) provides some of the latest findings in genitourinary cancers (including prostate, bladder, kidney and testicular cancers). This lecture will highlight some of the cutting-edge research findings presented at the 2018 meeting.
  • Participation
$0.00
Children with cancer, and their clinicians, face a unique spectrum of challenges. Differences in diagnosis, biology, treatment toxicity, and impact on social development require focused teams of researchers, healthcare providers, psychologist, and social workers. Novel diagnostic and treatment paradigms require intricate systems for data interpretation and therapy delivery, but come with a hope of improved survival and quality of life.
  • Participation
$0.00
This lecture will describe the rationale behind using immunotherapy in lung cancer, the current standard of care use of immunotherapy, and future directions.
  • Participation
$0.00
The most common lung cancers are known to have diverse pathological features and recent research has further identified distinct diseases with genetic and cellular heterogeneity. This lecture will provide strategies for managing this heterogeneity during clinical evaluation and treatment of patients.
  • Participation
$0.00
It is estimated 155,000 women in the US are living with metastatic breast cancer. 40,000 women die from this disease each year. Clearly new approaches are needed. This lecture will take a look current treatments and discuss advances in treatment that may lead to increases in overall survival and improvements in quality of life.
  • Participation
$0.00
This presentation will provide is an overview of melanoma from diagnosis through treatment. Through case-based format, the lecture will emphasize the changes that have taken place in the field in the last three years.  It will include information on basic biology that can be applied to the understanding of the treatment of other cancers and thoughts on research directions.
  • NCPD/CNE
  • Participation
$0.00
Ali Shazib, DMD, will highlight the field of oral medicine and its integration into the oncology landscape (oral oncology), identify oral complications associated with cancer therapies, practical approaches towards managing oral complications, and discuss the role of multi-disciplinary care through going through cases. The presentation will include challenges associated with oral care for patients undergoing cancer therapy and its role in survivorship and beyond.
  • NCPD/CNE
  • Participation
$0.00
Mary Peavey, MD, MSc, will provide an overview of the fertility preservation options available to male and female patients receiving treatment at UNC hospitals. She will also outline the steps to take when a patient expresses interest in exploring fertility preservation.
  • Participation
$0.00
Dr. Michael Lee from the UNC Lineberger Gastrointestinal Oncology group will describe relevant updates in systemic therapy for gastrointestinal cancers for health care providers throughout the state of North Carolina.

Pages